Detalles de la búsqueda
1.
Long-term efficacy, safety and tolerability of secukinumab in children and adolescents with severe chronic plaque psoriasis: Two-year results from a Phase III double-blind, randomized controlled trial.
J Eur Acad Dermatol Venereol
; 2023 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36971771
Resultados
1 -
1
de 1
1
Próxima >
>>